PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia. Electronic address: mhabek@mef.hr.\', \'Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia.\', \'Department of Neurology, University Hospital Center \'Sestre Milosrdnice\', Zagreb, Croatia.\', \'Clinical Institute for Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia. Electronic address: predstojnik.lab@kbc-zagreb.hr.\', \'Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia.\', \'Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia. Electronic address: andreja.emersic@kclj.si.\', \'Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia. Electronic address: alenka.horvat@kclj.si.\', \'Clinical Institute for Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia. Electronic address: ilapic@kbc-zagreb.hr.\', \'Clinical Institute for Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia. Electronic address: dsegulja@kbc-zagreb.hr.\', \'Department for Laboratory Diagnostics, Special Hospital AGRAM, Zagreb, Croatia. Electronic address: koraljka.duric@agram-bolnica.hr.\', \'Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia.\', \'Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia; Faculty of Electrical Engineering and Computing, University of Zagreb, Zagreb, Croatia.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0165-5728(21)00223-X10.1016/j.jneuroim.2021.577696
?:doi
?:hasPublicationType
?:journal
  • Journal of neuroimmunology
is ?:pmid of
?:pmid
?:pmid
  • 34418815
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.083
?:rankingScore_hIndex
  • 127
is ?:relation_isRelatedTo_publication of
?:title
  • Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34418815>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34418815>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all